I've noticed some chatter about $SLS possibly being a buyout target, especially after they amended executive agreements. This could signal significant changes ahead. I'm looking to build a position as this might rise on any news of a buyout.

I'm seeing major potential with SELLAS Life Sciences, especially with the upcoming Phase 3 data for GPS. The heavy investment from big funds signals confidence in the company's future. I believe that if this stock drops below $1, it's a solid buy, given the upcoming catalysts and potential partnership in the works.

I'm really optimistic about Sellas Life Sciences right now, especially with the RPDD designation for GPS. The upcoming interim analysis of the REGAL trial could trigger a strong move in the stock, and with the potential for big partnerships or mergers, it’s time to get in before any price jumps.